The Times recently featured Elcella as part of a growing shift toward gut-led, science-backed appetite regulation. The article highlights the decade of human-based research behind Elcella, led by Dr Madusha Peiris and Dr Ruby Aktar, and how their work on L-cells (the gut cells that release natural GLP-1 and PYY) shaped our approach.
Instead of overriding the appetite system, Elcella supports the body’s own pathways, grounded in clinical research at Queen Mary University of London. The feature places Elcella within a new wave of natural metabolic innovation.
To read the full article, click here.



Leave a comment
This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.